CARSON CITY, NV / March 9, 2017 / Cell MedX Corp. (CMXC), (“Cell MedX” or the “Company”), is pleased to announce that Dr. Richard Tytus, the Lead Investigator on the previously announced Observational Clinical Trial (the “Trial”), and his team…
Carson City, Nevada, March 1, 2017, Cell MedX Corp. (OTCQB: CMXC), Cell MedX Corp. (“Cell MedX” or the “Company”), is happy to announce that it has received an approval from the Ethics Review Board to commence its observational clinical trial…
CARSON CITY, NV / ACCESSWIRE / February 24, 2017 / Cell MedX Corp. (OTCQB: CMXC) (“Cell MedX” or the “Company”), an early development stage bio-tech company focusing on the discovery, development, and commercialization of therapeutic and non-therapeutic products that promote…
Carson City, Nevada, January 30, 2017, Cell MedX Corp. (OTCQB: CMXC), Cell MedX Corp. (“Cell MedX” or the “Company”), an early development stage bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general…
CARSON CITY, NV / ACCESSWIRE / January 23, 2017 / Cell MedX Corp. (CMXC), Cell MedX Corp. (“Cell MedX” or the “Company”), is happy to announce that it has received an approval from Health Canada to commence its observational clinical…
CARSON CITY, NV / ACCESSWIRE / January 10, 2017 / Cell MedX Corp. (CMXC), Cell MedX Corp. (“Cell MedX” or the “Company”), announces that it has received more positive observational results from our distributor, Mr. Greg Pek, in Manilla, Philippines.…
Carson City, Nevada, January 9, 2017, Cell MedX Corp. (OTCQB: CMXC), Cell MedX Corp. (“Cell MedX” or the “Company”), is pleased to announce that it has received its first eBalance Pro wellness devices ready for commercial distribution. These wellness devices…
LAS VEGAS, NV–(Nov 21, 2016) – Cell MedX Corp. (OTCQB: CMXC), Cell MedX Corp. (“Cell MedX” or the “Company”), a development stage bio-tech company focused on the commercialization and development of microcurrent therapeutic devices that promote general wellness and alleviate…
LAS VEGAS, NV / November 8, 2016 / Cell MedX Corp. (CMXC) (“Cell MedX” or the “Company”), a development stage company focused on the commercialization of therapeutic devices for patients living with diseases such as diabetes, is pleased to announce…
Las Vegas, Nevada, October 13, 2016, Cell MedX Corp. (OTCQB: CMXC), (“Cell MedX” or the “Company”) a development stage company focused on the commercialization of therapeutic devices for patients living with diseases such as diabetes, is pleased to announce that…